Marathon Petroleum closed September 9 at $399.44, about 0.6% below its 52-week high of $402. The stock has gained roughly 116% over the past year, and for once the fundamentals justify every point of that move. The question now is whether there is more.

Why This Stock Now

On September 8, UBS raised its price target on Marathon to $450 from $321, a $129 increase, and held its Buy rating. That target sits about 12.6% above the September 9 close and roughly $120 above the broader Street consensus of $330, illustrating how decisively one analyst broke from the pack on the refining cycle. What UBS is pricing in, and most of Wall Street is still underwriting conservatively, is that elevated crack spreads are not transitory.

The Business

Marathon is the largest U.S. refiner by volume, operating approximately 3 million barrels per day of refining capacity across 13 facilities. It also holds a majority stake in MPLX LP, one of North America’s largest midstream operators. That structure matters: MPLX generates stable, fee-based cash flows that cushion earnings when refining margins fluctuate. In Q2 2026, the combination produced $8.5 billion in adjusted EBITDA and net income of $5.1 billion, or $17.73 per diluted share. The same quarter a year ago: $1.2 billion in net income, $3.96 per share. That is not normal cyclical upside. It is an operating leverage inflection.

Why Wall Street Is Paying Attention

The refining margin that drove Q2 numbers reached $36.33 per barrel, more than double the $17.58 per barrel recorded a year earlier. Higher crack spreads across all regions, driven in large part by the effective shutdown of navigation through the Strait of Hormuz after February’s escalation with Iran, compressed global refined product supply while U.S. refiners, Marathon in particular, ran at 94% crude capacity utilization. Diesel prices climbed to record highs in early September. Gasoline exceeded $4 per gallon nationally in August. Marathon’s refineries, already optimized through a multi-year capital program, captured more of those spreads than at any point in the past four years.

What’s Driving the Opportunity

Marathon has reduced its share count by roughly 5.8% in the first half of 2026 compared with the same period a year earlier. It returned more than $2.8 billion to shareholders in Q2 alone and had $6.1 billion remaining under existing buyback authorizations at quarter-end. MPLX raised its 2026 growth capital outlook by $500 million to $2.9 billion, accelerating its Gulf Coast fractionation and LPG export projects expected to begin service in 2028 and 2029. Management is guiding for 12.5% annual distribution growth from MPLX in both 2026 and 2027. Falling share count plus rising distributions from a midstream subsidiary is a compounding mechanism that most energy models still discount.

What Could Go Wrong

Refining is structurally cyclical. The $36.33 per barrel margin that powered Q2 results is not a guaranteed baseline. If tensions in the Middle East ease materially, Strait of Hormuz flows normalize, and global refined product supply recovers, crack spreads could compress sharply. Marathon’s earnings would fall with them, regardless of operational efficiency. Brent crude traded above $100 a barrel in early September. At $400 a share, the stock offers limited margin of safety if the cycle turns.

The Bottom Line

Marathon Petroleum earned $17.73 per share in a single quarter. It returned nearly $3 billion to shareholders in the same period. Its midstream subsidiary is accelerating investment. UBS sees $450. The bear case is that this cycle peaks and margins compress; the bull case is that the Strait of Hormuz disruption has structurally reset the value of U.S. refining capacity in a way that takes years, not quarters, to unwind. At 116% year-over-year, the stock has already made believers of the market. The data suggests there is more to run.